An industry update: the latest developments in therapeutic delivery.

Area of Science:

• Drug Delivery Systems
• Nanotechnology in Medicine
• Medical Device Innovation

Background:

• The drug delivery landscape is evolving rapidly, driven by the need for enhanced safety, efficacy, and patient compliance.
• Traditional drug delivery methods face limitations in controlling release kinetics and targeting specific sites.
• Emerging technologies aim to overcome these challenges by improving drug administration and patient experience.

Purpose of the Study:

• To provide an industry update on drug delivery innovations from June 2017.
• To highlight the transition of advanced drug delivery technologies from research and development to clinical application and market.
• To identify key trends and emerging technologies in the drug delivery sector.

Main Methods:

• Information synthesis from company press releases.
• Analysis of data from regulatory and patent agencies.
• Review of relevant scientific literature.

Main Results:

• Improved and safer injectables, patches, and nanocarriers are progressing towards market availability.
• Local drug delivery methods (e.g., intraocular) and nanotechnology applications (e.g., nanocarriers, microneedles) show significant potential.
• Mobile applications and connected devices are increasingly integrated for drug dosing monitoring and closed-loop systems.

Conclusions:

• Drug delivery innovation is driven by safety, efficacy, cost-effectiveness, and patient comfort.
• Nanotechnology and connected devices represent key 21st-century technologies transforming drug delivery.
• Industry convergence of diverse capabilities is a growing trend among pharmaceutical and technology companies.